TinyGemsBreaks – Bell2Bell Podcast Features Walk-in Dermatology CEO Steven Dresner

Walk-in Dermatology is transforming patient access to dermatological care by combining the convenience of urgent care with the expertise of traditional dermatology. In the latest Bell2Bell podcast, Steven Dresner, CEO of Walk-in Dermatology, discusses the company’s mission to provide same-day, high-quality dermatology services without the long wait times typical of traditional practices. Dresner explains how the model serves patients who need immediate care for conditions like rashes or acne but face delays in scheduling with conventional dermatologists. 

Join IBN’s Carmel Fisher and Dresner as they examine Walk-in Dermatology’s business model, including patient acquisition costs and visit frequency, and how it compares to traditional dermatology practices. 

To listen to the episode, visit https://ibn.fm/iAI9B 

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Austin, Texas
www.TinyGems.com
512.354.7000 Office
Editor@TinyGems.com

TinyGems is powered by IBN

Alex Pearon

Share
Published by
Alex Pearon

Recent Posts

TinyGemsBreaks – PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Secures $1.74 Million in Funding for Three Nova Scotia Community Solar Projects

Disseminated on behalf of PowerBank Corporation PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103), announced…

10 hours ago

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Closes $7 Million Public Offering 

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion systems with a…

11 hours ago

TinyGemsBreaks – Standard Lithium Ltd. (NYSE American: SLI) Appoints Michael Lutgring as General Counsel 

Standard Lithium (NYSE American: SLI), a near-commercial lithium company, has appointed Michael Lutgring as General…

1 day ago

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) CEO Featured on Latest Episode of IBN’s GotStocks Podcast

SEGG Media (NASDAQ: SEGG, LTRYW), a technology leader at the nexus of sports, entertainment, and…

1 day ago

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Prices $7 Million Public Offering of Common Stock and Pre-Funded Warrants

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion systems and multi-brand…

1 day ago

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for cancers in the brain and…

4 days ago